Treatment of localised renal cell carcinoma

Hein Van Poppel, Frank Becker, Jeffrey A. Cadeddu, Inderbir S. Gill, Gunther Janetschek, Michael A S Jewett, M. Pilar Laguna, Michael Marberger, Francesco Montorsi, Thomas J. Polascik, Osamu Ukimura, Gang Zhu

Research output: Contribution to journalArticlepeer-review


Context: The increasing incidence of localised renal cell carcinoma (RCC) over the last 3 decades and controversy over mortality rates have prompted reassessment of current treatment. Objective: To critically review the recent data on the management of localised RCC to arrive at a general consensus. Evidence acquisition: A Medline search was performed from January 1, 2004, to May 3, 2011, using renal cell carcinoma, nephrectomy (Medical Subject Heading [MeSH] major topic), surgical procedures, minimally invasive (MeSH major topic), nephron-sparing surgery, cryoablation, radiofrequency ablation, surveillance, and watchful waiting. Evidence synthesis: Initial active surveillance (AS) should be a first treatment option for small renal masses (SRMs)

Original languageEnglish
Pages (from-to)662-672
Number of pages11
JournalEuropean Urology
Issue number4
Publication statusPublished - Oct 2011


  • Active surveillance
  • Cryotherapy
  • Nephron-sparing surgery
  • Partial nephrectomy
  • Radical nephrectomy
  • Radiofrequency ablation
  • Renal cell carcinoma
  • Small renal mass

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Treatment of localised renal cell carcinoma'. Together they form a unique fingerprint.

Cite this